tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

TNGX Stock Latest News

Tango Therapeutics treatment of pancreatic cancer granted orphan designation
The FlyTango Therapeutics treatment of pancreatic cancer granted orphan designation
25d ago
TNGX
Tango Therapeutics price target lowered to $8 from $16 at B. Riley
PremiumThe Fly
Tango Therapeutics price target lowered to $8 from $16 at B. Riley
1M ago
TNGX
Tango Therapeutics price target lowered to $8 from $18 at Guggenheim
PremiumThe Fly
Tango Therapeutics price target lowered to $8 from $18 at Guggenheim
2M ago
TNGX
Tango Therapeutics Advances Cancer Treatment Pipeline
PremiumCompany Announcements
Tango Therapeutics Advances Cancer Treatment Pipeline
2M ago
TNGX
Trump Media, broader market surge after Trump wins election: Morning Buzz
PremiumThe Fly
Trump Media, broader market surge after Trump wins election: Morning Buzz
2M ago
OC
CVS
Tango Therapeutics reports Q3 EPS (27c), consensus (37c)
PremiumThe FlyTango Therapeutics reports Q3 EPS (27c), consensus (37c)
2M ago
TNGX
Tango Therapeutics announces update on PRMT5 program
Premium
The Fly
Tango Therapeutics announces update on PRMT5 program
2M ago
TNGX
Short Report: Archer Aviation shorts at seven-week high
Premium
The Fly
Short Report: Archer Aviation shorts at seven-week high
2M ago
ACHR
BMEA
Jefferies Predicts up to 270% Rally for These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & Ideas
Jefferies Predicts up to 270% Rally for These 2 ‘Strong Buy’ Stocks
4M ago
INZY
TNGX
Tango Therapeutics price target raised to $13 from $11 at Wedbush
PremiumThe Fly
Tango Therapeutics price target raised to $13 from $11 at Wedbush
5M ago
TNGX
Tango Therapeutics reports Q2 EPS (24c), consensus (34c)
PremiumThe Fly
Tango Therapeutics reports Q2 EPS (24c), consensus (34c)
5M ago
GILD
TNGX
Tango Therapeutics initiated with a Buy at Jefferies
PremiumThe Fly
Tango Therapeutics initiated with a Buy at Jefferies
5M ago
TNGX
Tango Therapeutics price target lowered to $13 from $16 at H.C. Wainwright
PremiumThe FlyTango Therapeutics price target lowered to $13 from $16 at H.C. Wainwright
7M ago
TNGX
Tango Therapeutics price target lowered to $14 from $16 at Guggenheim
Premium
The Fly
Tango Therapeutics price target lowered to $14 from $16 at Guggenheim
7M ago
TNGX
Tango Therapeutics price target lowered to $13 from $18 at Barclays
Premium
The Fly
Tango Therapeutics price target lowered to $13 from $18 at Barclays
7M ago
TNGX
Medivir licensee Tango Therapeutics discontinues TNG348 clinical program
PremiumThe Fly
Medivir licensee Tango Therapeutics discontinues TNG348 clinical program
7M ago
TNGX
Tango Therapeutics to discontinue development of TNG348 program
PremiumThe Fly
Tango Therapeutics to discontinue development of TNG348 program
7M ago
TNGX
Tango Therapeutics reports Q1 EPS (35c), consensus (31c)
PremiumThe Fly
Tango Therapeutics reports Q1 EPS (35c), consensus (31c)
8M ago
TNGX
Cantor starts Tango Therapeutics with Overweight on tumor pipeline
PremiumThe Fly
Cantor starts Tango Therapeutics with Overweight on tumor pipeline
9M ago
TNGX
Tango Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyTango Therapeutics initiated with an Overweight at Cantor Fitzgerald
9M ago
TNGX
Tango Therapeutics price target raised to $17 from $16 at H.C. Wainwright
Premium
The Fly
Tango Therapeutics price target raised to $17 from $16 at H.C. Wainwright
9M ago
TNGX
Navigating the AI Minefield: Tango Therapeutics’ Struggle with Security Risks and EU Regulations
Premium
Company Announcements
Navigating the AI Minefield: Tango Therapeutics’ Struggle with Security Risks and EU Regulations
9M ago
TNGX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >